Skip to content

Creatinine - Jaffè

by Kalians Corporation 2 variants

Ref D-619 001, D-619 003, D-618 002

Creatinine - Jaffè (D-619 001) is an in vitro diagnostic device (EU IVDD general IVD; EMDN category creatinine) made by Kalians Corporation, registered in EUDAMED on 1 Apr 2026 (Basic UDI-DI B-62230182702328), active as of 22 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-62230182702328 Basic UDI-DI Date1 Apr 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Trade name
Creatinine - Jaffè
Creatinine - Jaffè (Single Reagent)
Model / reference
D-619 001, D-619 003, D-618 002
Primary DI / UDI-DI
62230182702328, 62230182702564, 62230182702250
Basic UDI-DI
B-62230182702328, B-62230182702564, B-62230182702250
EMDN code
W01010207 Creatinine
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
EG-MF-000050142
Authorised representative
MDSS GmbH DE-AR-000005430

Similar devices in this category

Other devices filed under CREATININE.

Other devices from Kalians Corporation

See all devices from Kalians Corporation →

Properties

  • Reagent
  • IVD kit
  • Professional testing
Other properties (9, all answered No)